Trial
NCT01261299
Clinical Study of Microdosing Carboplatin in Lung or Bladder Cancer
Early Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of California, Davis
Collaborators
Lawrence Livermore National Laboratory; National Institutes of Health (NIH)
Condition
Carcinoma, Non-Small-Cell Lung
Intervention
Carbon-14-labeled carboplatin
Why stopped
Contract ended
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-01-09